Design and Verification of a Novel Perfusion Bioreactor to Evaluate the Performance of a Self-Expanding Stent for Peripheral Artery Applications.

Frontiers in Medical Technology Pub Date : 2022-06-21 eCollection Date: 2022-01-01 DOI:10.3389/fmedt.2022.886458
Swati Nandan, Jessica Schiavi-Tritz, Rudolf Hellmuth, Craig Dunlop, Ted J Vaughan, Eimear B Dolan
{"title":"Design and Verification of a Novel Perfusion Bioreactor to Evaluate the Performance of a Self-Expanding Stent for Peripheral Artery Applications.","authors":"Swati Nandan,&nbsp;Jessica Schiavi-Tritz,&nbsp;Rudolf Hellmuth,&nbsp;Craig Dunlop,&nbsp;Ted J Vaughan,&nbsp;Eimear B Dolan","doi":"10.3389/fmedt.2022.886458","DOIUrl":null,"url":null,"abstract":"<p><p>Endovascular stenting presents a promising approach to treat peripheral artery stenosis. However, a significant proportion of patients require secondary interventions due to complications such as in-stent restenosis and late stent thrombosis. Clinical failure of stents is not only attributed to patient factors but also on endothelial cell (EC) injury response, stent deployment techniques, and stent design. Three-dimensional <i>in vitro</i> bioreactor systems provide a valuable testbed for endovascular device assessment in a controlled environment replicating hemodynamic flow conditions found <i>in vivo</i>. To date, very few studies have verified the design of bioreactors based on applied flow conditions and their impact on wall shear stress, which plays a key role in the development of vascular pathologies. In this study, we develop a computationally informed bioreactor capable of capturing responses of human umbilical vein endothelial cells seeded on silicone tubes subjected to hemodynamic flow conditions and deployment of a self-expanding nitinol stents. Verification of bioreactor design through computational fluid dynamics analysis confirmed the application of pulsatile flow with minimum oscillations. EC responses based on morphology, nitric oxide (NO) release, metabolic activity, and cell count on day 1 and day 4 verified the presence of hemodynamic flow conditions. For the first time, it is also demonstrated that the designed bioreactor is capable of capturing EC responses to stent deployment beyond a 24-hour period with this testbed. A temporal investigation of EC responses to stent implantation from day 1 to day 4 showed significantly lower metabolic activity, EC proliferation, no significant changes to NO levels and EC's aligning locally to edges of stent struts, and random orientation in between the struts. These EC responses were indicative of stent-induced disturbances to local hemodynamics and sustained EC injury response contributing to neointimal growth and development of in-stent restenosis. This study presents a novel computationally informed 3D <i>in vitro</i> testbed to evaluate stent performance in presence of hemodynamic flow conditions found in native peripheral arteries and could help to bridge the gap between the current capabilities of 2D <i>in vitro</i> cell culture models and expensive pre-clinical <i>in vivo</i> models.</p>","PeriodicalId":12599,"journal":{"name":"Frontiers in Medical Technology","volume":" ","pages":"886458"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253816/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medical Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fmedt.2022.886458","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Endovascular stenting presents a promising approach to treat peripheral artery stenosis. However, a significant proportion of patients require secondary interventions due to complications such as in-stent restenosis and late stent thrombosis. Clinical failure of stents is not only attributed to patient factors but also on endothelial cell (EC) injury response, stent deployment techniques, and stent design. Three-dimensional in vitro bioreactor systems provide a valuable testbed for endovascular device assessment in a controlled environment replicating hemodynamic flow conditions found in vivo. To date, very few studies have verified the design of bioreactors based on applied flow conditions and their impact on wall shear stress, which plays a key role in the development of vascular pathologies. In this study, we develop a computationally informed bioreactor capable of capturing responses of human umbilical vein endothelial cells seeded on silicone tubes subjected to hemodynamic flow conditions and deployment of a self-expanding nitinol stents. Verification of bioreactor design through computational fluid dynamics analysis confirmed the application of pulsatile flow with minimum oscillations. EC responses based on morphology, nitric oxide (NO) release, metabolic activity, and cell count on day 1 and day 4 verified the presence of hemodynamic flow conditions. For the first time, it is also demonstrated that the designed bioreactor is capable of capturing EC responses to stent deployment beyond a 24-hour period with this testbed. A temporal investigation of EC responses to stent implantation from day 1 to day 4 showed significantly lower metabolic activity, EC proliferation, no significant changes to NO levels and EC's aligning locally to edges of stent struts, and random orientation in between the struts. These EC responses were indicative of stent-induced disturbances to local hemodynamics and sustained EC injury response contributing to neointimal growth and development of in-stent restenosis. This study presents a novel computationally informed 3D in vitro testbed to evaluate stent performance in presence of hemodynamic flow conditions found in native peripheral arteries and could help to bridge the gap between the current capabilities of 2D in vitro cell culture models and expensive pre-clinical in vivo models.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一种新型灌注生物反应器的设计与验证,以评估外周动脉自扩张支架的性能。
血管内支架植入术是治疗外周动脉狭窄的一种很有前途的方法。然而,由于支架内再狭窄和晚期支架血栓形成等并发症,很大一部分患者需要二次干预。支架的临床失败不仅归因于患者因素,还与内皮细胞(EC)损伤反应、支架部署技术和支架设计有关。三维体外生物反应器系统为在受控环境下对血管内装置进行评估提供了一个有价值的测试平台,可以复制体内血液动力学流动条件。迄今为止,很少有研究证实基于应用流动条件及其对壁面剪切应力的影响来设计生物反应器,而壁面剪切应力在血管病变的发展中起着关键作用。在这项研究中,我们开发了一种计算信息生物反应器,能够捕捉人脐静脉内皮细胞在血液动力学流动条件下的反应,并部署自膨胀镍钛诺支架。通过计算流体动力学分析对生物反应器设计的验证,证实了最小振荡脉动流的应用。在第1天和第4天,基于形态学、一氧化氮(NO)释放、代谢活性和细胞计数的EC反应证实了血流动力学条件的存在。该实验还首次证明,设计的生物反应器能够在24小时内捕获EC对支架部署的反应。从第1天到第4天对支架植入EC反应的时间调查显示,代谢活性显著降低,EC增殖,no水平无显著变化,EC局部对准支架支架边缘,支架之间的方向随机。这些EC反应表明支架引起的局部血流动力学紊乱和持续的EC损伤反应有助于内膜生长和支架内再狭窄的发展。本研究提出了一种新的3D体外测试平台,用于评估在天然外周动脉中发现的血流动力学流动条件下支架的性能,并有助于弥合目前2D体外细胞培养模型和昂贵的临床前体内模型之间的差距。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Case Report: The effect of automated manual lymphatic drainage therapy on lymphatic contractility in 4 distinct cases Detection of natural autoimmunity to ghrelin in diabetes mellitus Ensuring safety and efficacy in combination products: regulatory challenges and best practices Augmented reality-based software (Echo-QR) for guiding the echographic probe toward the acoustic window: a pilot study Ethical considerations in the regulation and use of herbal medicines in the European Union
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1